ALNYLAM PHARMACEUTICALS, INC.: operating_income

Value{"amount": 501578000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2025-01-01 – 2025-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-26-007497
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/operating-income/2025-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a68b399f-9697-4f26-8e6c-aef54f4f31f1

History